Chardan Capital Initiates Ophthotech At Buy

Analysts at Chardan Capital initiated coverage on Ophthotech Corporation OPHT with a Buy rating. The target price for Ophthotech is set to $80. Ophthotech shares have gained 47.77% over the past 52 weeks, while the S&P 500 index has surged 14.85% in the same period. Ophthotech shares rose 1.29% to $54.00 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst RatingsChardan Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!